Work

A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer

Year: 2019

Type: article

Study design: Clinical Trial

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2019.08.009

Authors: Liza C. Villaruz, Manuel Cobo, Konstantinos Syrigos, Dimitrios Mavroudis, Wei Zhang, Jong Seok Kim, Mark A. Socinski

Institutions: UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Hospital Regional Universitario de Málaga, National and Kapodistrian University of Athens, University Hospital of Heraklion, Eli Lilly (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2969184458

FWCI: 0.734

Cites: 15

Cited by: 8

Related to: 10